Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about IRONWOOD PHARMACEUTICALS,
05/10 IRONWOOD PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch Healt..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide's Effec..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide’s..
05/08 IRONWOOD PHARMACEUTICALS, INC. (NASD : IRWD) reported earnings of ($0.36) per sh..
05/08 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
05/08 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/08 IRONWOOD PHARMACEUTICALS : Provides First Quarter 2017 Investor Update
05/01 IRONWOOD PHARMACEUTICALS : to Present New Data for Linaclotide, Linaclotide Dela..
04/24 IRONWOOD PHARMACEUTICALS : to Host First Quarter 2017 Investor Update Call
04/18 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Departure of Directors..
04/10 IRONWOOD PHARMACEUTICALS : appoints chief development officer
04/06 IRONWOOD PHARMACEUTICALS : Appoints Dr. Christopher Wright as Senior Vice Presid..
03/30 IRONWOOD PHARMACEUTICALS : Guggenheim Capital LLC Decreases Stake in Ironwood Ph..
03/10 IRONWOOD PHARMACEUTICALS : to Present at Barclays Global Healthcare Conference
03/09 IRONWOOD PHARMACEUTICALS : Showcases Progress Delivering Innovative Medicines to..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
05/25 IRONWOOD PHARMACEUTICALS : Patent Issued for Treatments for Gastrointestinal Dis..
05/18 IRONWOOD PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch Healt..
05/10 IRONWOOD PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch Healt..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide's Effec..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide’s..
05/08 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
05/08 IRONWOOD PHARMACEUTICALS, INC. (NASD : IRWD) reported earnings of ($0.36) per sh..
05/08 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
05/08 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/08 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
More news
Sector news : Biotechnology & Medical Research - NEC
05/23 UK competition watchdog accuses Merck of obstructing biosimilars
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJAMGEN : Another Gloomy Day for Amgen
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09DJVERTEX PHARMACEUTICALS INCORPORATED : Trump's Pick to Lead FDA Has Backing of Bi..
05/07 REGENERON SHARES POISED FOR REBOUND : Barron's
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/15 Ardelyx Runs Into Problems With Tenapanor
05/12 Why Ardelyx's Positive Results Still Aren't Up To Par
05/12 BIOTECH FORUM DAILY DIGEST : Keytruda Continues To Gain Momentum. Revisiting Ami..
05/10 SYNERGY PHARMACEUTICALS : An Overlooked $4 Biopharma Stock
05/10 RECAP OF SYNERGY PHARMACEUTICALS AFT : Ironwood's Beginning Of The End
05/10 BIOTECH FORUM DAILY DIGEST : Biotech Continues To Meander; Revisiting Invitae
Latest Tweets
05/24Nice breakouts straight from the nightly newsletter!
1
05/24Sullivan Bruyette Speros & Blaney LLC Raises Stake in Ironwood Pharmaceut.. 
05/19DekaBank Deutsche Girozentrale Has $1.047 Million Stake in Ironwood Pharmaceu.. 
05/19Ironwood Pharmaceuticals, Inc. $IRWD Insider Sells $546,000.00 in Stock  
05/18Ironwood Pharmaceuticals $IRWD Getting Somewhat Critical Media Coverage, Stud.. 
More tweets
Qtime:15
Advertisement
Financials ($)
Sales 2017 300 M
EBIT 2017 -99,2 M
Net income 2017 -121 M
Debt 2017 188 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 9,86x
EV / Sales 2018 7,30x
Capitalization 2 767 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 17,6 $
Spread / Average Target -5,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..21.78%2 767
INCYTE CORPORATION34.02%27 518
QUINTILES IMS HOLDINGS..13.11%18 872
LONZA GROUP AG25.78%15 703
CELLTRION, INC.--.--%10 293
SEATTLE GENETICS, INC.24.26%9 358
More Results